Nicholas E Johnson1, Anne-Berit Ekstrom2, Craig Campbell3, Man Hung4,5, Heather R Adams6, Wei Chen5, Elizabeth Luebbe6, James Hilbert6, Richard T Moxley6, Chad R Heatwole6. 1. Department of Neurology, The University of Utah, Salt Lake City, UT, USA. 2. Department of Pediatrics, The Queen Silvia Children's Hospital, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. 3. Department of Neurology, London Health Science Centre, London, ON, Canada. 4. Department of Orthopedics, The University of Utah, Salt Lake City, UT, USA. 5. Division of Epidemiology, The University of Utah, Salt Lake City, UT, USA. 6. Department of Neurology, The University of Rochester, Rochester, NY, USA.
Abstract
AIM: The frequency and impact of symptoms experienced by patients with congenital, childhood, and juvenile-onset myotonic dystrophy (CDM/ChDM/JDM) is not documented. This report identifies symptomatic areas with the greatest disease burden in an international population of patients with early-onset myotonic dystrophy type-1 (DM1). METHOD: We distributed surveys to parents of patients with CDM/ChDM/JDM. Patients with CDM/ChDM/JDM were members of the US National Registry of DM1 Patients and Family Members, the Canadian Neuromuscular Disease Registry, or the Swedish Health System. Surveys inquired about 325 symptoms and 20 themes associated with CDM/ChDM/JDM. Parents identified the importance of each symptom and theme to their affected child. The prevalence of each symptom and theme were compared across subgroups of patients. The statistical analysis was performed using Fisher's exact and Kruskal-Wallis tests. RESULTS: One hundred and fifty parents returned surveys. The most frequently reported symptomatic themes in children were issues involving communication (81.7%) and problems with hands or fingers (79.6%). Problems with communication and fatigue were the issues that were reported to have the greatest impact on childrens' lives, while 24.1% of children reported cardiac disorders and 15.8% had problems with anesthesia. INTERPRETATION: A range of symptoms contribute to the burden of disease faced by children with DM1. Many of these symptoms are under-recognized.
AIM: The frequency and impact of symptoms experienced by patients with congenital, childhood, and juvenile-onset myotonic dystrophy (CDM/ChDM/JDM) is not documented. This report identifies symptomatic areas with the greatest disease burden in an international population of patients with early-onset myotonic dystrophy type-1 (DM1). METHOD: We distributed surveys to parents of patients with CDM/ChDM/JDM. Patients with CDM/ChDM/JDM were members of the US National Registry of DM1Patients and Family Members, the Canadian Neuromuscular Disease Registry, or the Swedish Health System. Surveys inquired about 325 symptoms and 20 themes associated with CDM/ChDM/JDM. Parents identified the importance of each symptom and theme to their affected child. The prevalence of each symptom and theme were compared across subgroups of patients. The statistical analysis was performed using Fisher's exact and Kruskal-Wallis tests. RESULTS: One hundred and fifty parents returned surveys. The most frequently reported symptomatic themes in children were issues involving communication (81.7%) and problems with hands or fingers (79.6%). Problems with communication and fatigue were the issues that were reported to have the greatest impact on childrens' lives, while 24.1% of children reported cardiac disorders and 15.8% had problems with anesthesia. INTERPRETATION: A range of symptoms contribute to the burden of disease faced by children with DM1. Many of these symptoms are under-recognized.
Authors: James E Hilbert; John T Kissel; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Donald B Sanders; Rabi Tawil; Charles A Thornton; Richard T Moxley Journal: Contemp Clin Trials Date: 2011-11-26 Impact factor: 2.226
Authors: M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy Journal: Science Date: 1992-03-06 Impact factor: 47.728
Authors: Nicholas E Johnson; Elizabeth Luebbe; Eileen Eastwood; Nancy Chin; Richard T Moxley; Chad R Heatwole Journal: J Child Neurol Date: 2013-04-22 Impact factor: 1.987
Authors: J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson Journal: Cell Date: 1992-02-21 Impact factor: 41.582
Authors: Jeffrey R Wozniak; Bryon A Mueller; Christopher J Bell; Ryan L Muetzel; Kelvin O Lim; John W Day Journal: J Neurol Date: 2012-11-29 Impact factor: 4.849
Authors: Evan M Pucillo; Deanna L Dibella; Man Hung; Jerry Bounsanga; Becky Crockett; Melissa Dixon; Russell J Butterfield; Craig Campbell; Nicholas E Johnson Journal: Muscle Nerve Date: 2017-02-13 Impact factor: 3.217
Authors: Kiera N Berggren; Man Hung; Melissa M Dixon; Jerry Bounsanga; Becky Crockett; Mary D Foye; Yushan Gu; Craig Campbell; Russell J Butterfield; Nicholas E Johnson Journal: Muscle Nerve Date: 2018-09 Impact factor: 3.217
Authors: Nicholas E Johnson; Chad Heatwole; Peter Creigh; Michael P McDermott; Nuran Dilek; Man Hung; Jerry Bounsanga; Wan Tang; Michael E Shy; David N Herrmann Journal: Ann Neurol Date: 2018-08-29 Impact factor: 10.422
Authors: Patrícia Sofia Ferreira Miranda; Ester Preciosa Maio Nunes Pereira; Joana Serra Caetano Baltazar Barreto; Margarida Maria Videira Henriques; Maria Alice Santos Cordeiro Mirante; Lina Maria Jesus Ferreira Cardoso Ramos Journal: Rev Paul Pediatr Date: 2020-02-14
Authors: Mieke Kooi-van Es; Corrie E Erasmus; Bert J M de Swart; Nicoline B M Voet; Philip J van der Wees; Imelda J M de Groot; Lenie van den Engel-Hoek Journal: J Neuromuscul Dis Date: 2020